Lipella Pharmaceuticals Inc (LIPO)

02:30 AM

Lipella Pharmaceuticals completes dosing for first cohort in LP-310 trial - MSN

02:30 AM

05:32 AM

Lipella Pharmaceuticals Announces Completion of First - GlobeNewswire

05:32 AM

05:30 AM

Lipella's LP-310 OLP Treatment Advances in Phase 2a Trial with Promising Safety Data | LIPO Stock News - StockTitan

05:30 AM

Nov 20, 2024

Lipella Pharmaceuticals Faces Nasdaq Delisting Risk Amid Compliance Challenges - MSN

Nov 20, 2024

Nov 17, 2024

Lipella Pharmaceuticals Third Quarter 2024 Earnings: US$1.29 loss per share (vs US$1.84 loss in 3Q 2023) - Yahoo Finance

Nov 17, 2024

Nov 15, 2024

LIPO stock touches 52-week low at $2.21 amid market challenges - Investing.com

Nov 15, 2024

Nov 15, 2024

Lipella Pharmaceuticals Inc (LIPO) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 14, 2024

Lipella Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024

Nov 12, 2024

Lipella issued patent by USPTO for liposomal drug delivery platform - TipRanks

Nov 12, 2024

Nov 12, 2024

Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform - The Manila Times

Nov 12, 2024

Nov 12, 2024

Lipella Pharmaceuticals Secures Extended Market Exclusivity - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Lipella Pharma Secures Key Patent for Liposomal Platform, Extends Drug Pipeline Protection to 2035 | LIPO Stock News - StockTitan

Nov 12, 2024

Nov 11, 2024

China chip index nears 3-year high as TSMC order fuels self-reliance bets - Investing.com

Nov 11, 2024

Nov 08, 2024

Cathay general bancorp vice chairman sells $2.11 million in stock - Investing.com

Nov 08, 2024

Nov 06, 2024

Contrasting Wellness Center USA (OTCMKTS:WCUI) & Lipella Pharmaceuticals (NASDAQ:LIPO) - Defense World

Nov 06, 2024

Nov 05, 2024

Lipella Pharmaceuticals stock hits 52-week low at $0.32 - Investing.com India

Nov 05, 2024

Nov 05, 2024

Lipella Pharmaceuticals stock hits 52-week low at $0.32 By Investing.com - Investing.com Australia

Nov 05, 2024

Nov 03, 2024

Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split - citybiz

Nov 03, 2024

Nov 01, 2024

Lipella Pharmaceuticals Launching 1-for-8 Reverse Stock Split - Marketscreener.com

Nov 01, 2024

Nov 01, 2024

Lipella Pharmaceuticals announces 1-for-8 reverse stock split - MSN

Nov 01, 2024

Nov 01, 2024

Lipella Pharmaceuticals announces 1-for-8 reverse stock split By Investing.com - Investing.com UK

Nov 01, 2024

Oct 29, 2024

Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference - GlobeNewswire

Oct 29, 2024

Oct 19, 2024

Lipella Pharmaceuticals faces Nasdaq delisting over equity shortfall - Investing.com India

Oct 19, 2024

Oct 18, 2024

Lipella Pharmaceuticals faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com South Africa

Oct 18, 2024

Oct 18, 2024

Biotech Alert: Searches spiking for these stocks today - TipRanks

Oct 18, 2024

Oct 16, 2024

Ocugen Inc (OCGN) rating initates by Maxim Group - Knox Daily

Oct 16, 2024

Oct 16, 2024

Potential Price Increase for First Advantage Corp. (FA) After Recent Insider Activity - Knox Daily

Oct 16, 2024

Oct 16, 2024

Lipella Pharmaceuticals Inc (LIPO) Becoming More Attractive for Investors - Knox Daily

Oct 16, 2024

Oct 16, 2024

Recent Insider Activity Suggests Potential Gains for KE Holdings Inc ADR (BEKE) - Knox Daily

Oct 16, 2024

Oct 16, 2024

Lipella Pharmaceuticals Inc [LIPO] is -57.84% lower this YTD. Is it still time to buy? - The DBT News

Oct 16, 2024

Oct 15, 2024

Allovir (ALVR) Stock Experiences Significant Decline Amid Negati - GuruFocus.com

Oct 15, 2024

Oct 15, 2024

Huge semiconductor deal has eyes on this tech co 👀 - RagingBull

Oct 15, 2024

Oct 15, 2024

Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform - GlobeNewswire

Oct 15, 2024

Oct 13, 2024

Interstitial Cystitis Market Size is Set for Rapid Growth as - openPR

Oct 13, 2024

Oct 09, 2024

Sky Quarry Announces Closing of Public Offering of $6.7 Million - The Manila Times

Oct 09, 2024

Oct 09, 2024

TSX 60 Shariah Index (TXSI) QuotePress Release - The Globe and Mail

Oct 09, 2024

Oct 09, 2024

Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit - GlobeNewswire

Oct 09, 2024

Sep 30, 2024

Expion360 Inc’s latest rating changes from various analysts - Knox Daily

Sep 30, 2024

Sep 26, 2024

Insider Buying: Kaufman Jonathan H, Lipella Pharmaceuticals Inc [LIPO] insider invested 10,000 shares - Knox Daily

Sep 26, 2024

Sep 26, 2024

The time has not yet come to remove your chips from the table: Lipella Pharmaceuticals Inc (LIPO) - SETE News

Sep 26, 2024

Sep 25, 2024

Lipella Pharmaceuticals Inc Inc. (LIPO) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

Sep 25, 2024

Sep 25, 2024

PRISM MarketView Features Q&A with Dr. Michael Chancellor: - GlobeNewswire

Sep 25, 2024

Sep 25, 2024

PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month - Morningstar

Sep 25, 2024

Sep 24, 2024

Lipella reports positive phase 2a trial results for OLP treatment - Investing.com

Sep 24, 2024

Sep 24, 2024

Lipella Pharmaceuticals Reports Encouraging Early - GlobeNewswire

Sep 24, 2024

Sep 24, 2024

Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus - StockTitan

Sep 24, 2024

Sep 23, 2024

A year in review: Lipella Pharmaceuticals Inc (LIPO)’s performance in the last year - US Post News

Sep 23, 2024

Sep 23, 2024

Lipella Pharmaceuticals Inc’s Market Journey: Closing Weak at 0.41, Down -2.35 - The Dwinnex

Sep 23, 2024

Sep 23, 2024

Lipella stock soars 200% on Phase 2 study initiation - MSN

Sep 23, 2024

Sep 19, 2024

Matthew E Korenberg At Ligand Pharmaceuticals Executes Options Exercise, Realizing $260K - Benzinga

Sep 19, 2024